Glucose is the body’s primary energy currency. Every cell relies on it, from brain neurons firing to muscles contracting during exercise. Because glucose levels fluctuate throughout the day;, rising after meals and falling during fasting, the body has developed an intricate control system involving insulin, glucagon, and other hormones to keep levels within a healthy range. If glucose rises too high or drops too low, cellular function suffers, which over time can contribute to conditions like diabetes, cardiovascular disease, or even neurological decline.
When clinicians measure glucose, the way blood is processed matters. Plasma is the liquid part of blood that remains after red and white cells are removed but before clotting occurs. Serum, by contrast, is collected after clotting has finished. This difference is subtle but important: during clotting, blood cells continue consuming glucose, which can artificially lower the result. Plasma avoids this problem because it is processed immediately with an anticoagulant, preventing the loss of glucose. For this reason, plasma glucose is typically higher and more stable than serum glucose.
Guidelines from the International Federation of Clinical Chemistry and other expert groups recommend plasma glucose as the standard for diagnosing and monitoring diabetes. It is about 11 percent higher than whole blood glucose and more reliable than serum glucose. Using plasma reduces the risk of underestimating blood sugar levels, which could otherwise lead to a missed diagnosis.